Lixte Biotechnology Holdings, Inc. Warrants Insider Trading Activity
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Grant/Award: 22,600 shares
Grant/Award
2 txns
Insider
Brown Regina
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options to Purchase Common Stock | 10,000 | $0.00 | $0.00 |
| Grant/Award | Options to Purchase Common Stock | 12,600 | $0.00 | $0.00 |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
Holdings After Transaction:
Options to Purchase Common Stock — 113,205 options, with 90,605 underlying shares of Common (Direct)
Holdings Before and After:
Options to Purchase Common Stock, 90,605 to 113,205 options (Direct)
Footnotes (2)
- F1. Effective June 30, 2025, the reporting person was granted stock options to purchase an aggregate of 10,000 shares vesting in eight equal installments on the last day of each subsequent quarter until fully vested with vesting to start on September 30, 2025.
- F2. Effective June 30, 2025 the reporting person was granted stock options in aggregate of 12,600 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
